{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-012703","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2022-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.528055+00:00","generated_at":"2026-06-25T21:24:46.266400+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Interpace Biosciences issues $2M convertible note to BroadOak; conversion tied to PIPE of >=$10M","bullets":["$2M principal, 9% annual interest, unsecured, interest-only until Aug 5, 2022 maturity date.","Converts into common stock automatically if PIPE closing of at least $10M net proceeds occurs by maturity.","If PIPE not closed by Aug 5, 2022, converts into additional term loan under existing BroadOak subordinated facility.","Comerica Bank consented; note is subordinated to Comerica's senior secured debt.","Proceeds used for general corporate purposes and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-012703","json":"https://secwatch.observer/filing/0001493152-22-012703.json","markdown":"https://secwatch.observer/filing/0001493152-22-012703.md","text":"https://secwatch.observer/filing/0001493152-22-012703.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315222012703/0001493152-22-012703-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315222012703/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:24:46.266400+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}